Disruption of HPV 16 E1 and E2 genes in precancerous cervical lesions

Journal of Virological Methods

Volumn 158, Issue 1-2, 2009, Pages 180-183

  Cricca, Monica ^a   Venturoli, Simona ^a   Leo, Elisa ^a   Costa, Silvano ^b   Musiani, Monica ^a   Zerbini, Marialuisa ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Cervical lesion; E1 E2 genes; HPV 16; Integration site

Indexed keywords

VIRUS DNA;

ARTICLE; CLINICAL ARTICLE; DNA INTEGRATION; E2 GENE; FEMALE; GENE DELETION; GENE E1; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; NONHUMAN; PAPILLOMA; PRECANCER; PRIORITY JOURNAL; UTERINE CERVIX CANCER; VIRUS GENE;

DNA-BINDING PROTEINS; FEMALE; GENE DELETION; HUMAN PAPILLOMAVIRUS 16; HUMANS; MUTAGENESIS, INSERTIONAL; ONCOGENE PROTEINS, VIRAL; UTERINE CERVICAL NEOPLASMS; VIRUS INTEGRATION;

HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 64949162645     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2009.01.005     Document Type: Article

References (27)

1. Andersson S., Safari H., Mints M., Lewensohn-Fuchs I., Gyllensten U., and Johansson B. Type distribution, viral load and integration status of high risk human papillomaviruses in pre-stages of cervical cancer (CIN). Br. J. Cancer 92 (2005) 2195-2200
2. Arias-Pulido H., Peyton C.L., Joste N.E., Vargas H., and Wheeler C.M. Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer. J. Clin. Microbiol. 44 (2006) 1755-1762
3. Azizi N., Brazete J., Hankins C., Money D., Fontaine J., Koushik A., Rachlis A., Pourreaux K., Ferenczy A., Franco E., and Coutlée F. Influence of human papillomavirus type 16 (HPV-16) E2 polymorphism on quantification of HPV-16 episomal and integrated DNA in cervicovaginal lavages from women with cervical intraepithelial neoplasia. J. Gen. Virol. 89 (2008) 1716-1728
4. Baker C.C., Phelps W.C., Lindgren V., Braun M.J., Gonda M.A., and Howley P.M. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J. Virol. 61 (1987) 962-971
5. Bolger B.S., and Lewis B.V. A prospective study of colposcopy in women with mild dyscaryosis or koilocytosis. Br. J. Obstet. Gynaecol. 95 (1988) 1117-1119
6. Briolat J., Dalstein V., Saunier M., Joseph K., Caudroy S., Prétet J.L., Birembaut P., and Clavel C. HPV prevalence, viral load and physical state of HPV-16 in cervical smears of patients with different grades of CIN. Int. J. Cancer 121 (2007) 2198-2204
7. Chen C.M., Shyu M.P., Au L.C., Chu H.W., Cheng W.T., and Choo K.B. Analysis of deletion of the integrated human papillomavirus 16 sequence in cervical cancer: a rapid multiplex polymerase chain reaction approach. J. Med. Virol. 44 (1994) 206-211
8. Cricca M., Morselli-Labate A.M., Venturoli S., Ambretti S., Gentilomi G.A., Gallinella G., Costa S., Musiani M., and Zerbini M. Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV 16 positive women for high-grade cervical lesions. Gynecol. Oncol. 106 (2007) 549-557
9. De Marco L., Gillio-Tos A., Bonello L., Ghisetti V., Ronco G., and Merletti F. Detection of human papillomavirus type 16 integration in pre-neoplastic cervical lesions and confirmation by DIPS-PCR and sequencing. J. Clin. Virol. 38 (2007) 7-13
10. el Awady M.K., Kaplan J.B., O'Brien S.J., and Burk R.D. Molecular analysis of integrated human papillomavirus 16 sequences in the cervical cancer cell line SiHa. Virology 159 (1987) 389-398
11. Fujii T., Masumoto N., Saito M., Hirao N., Niimi S., Mukai M., Ono A., Hayashi S., Kubushiro K., Sakai E., Tsukazaki K., and Nozawa S. Comparison between in situ hybridization and real-time PCR technique as a means of detecting the integrated form of human papillomavirus 16 in cervical neoplasia. Diagn. Mol. Pathol. 14 (2005) 103-108
12. Gallo G., Bibbo M., Bagella L., Zamparelli A., Sanseverino F., Giovagnoli M.R., Vecchione A., and Giordano A. Study of viral integration of HPV-16 in young patients with LSIL. J. Clin. Pathol. 56 (2003) 532-536
13. Gravitt P.E., Peyton C., Wheeler C., Apple R., Higuchi R., and Shah K.V. Reproducibility of HPV 16 and HPV 18 viral load quantitation using TaqMan real-time PCR assays. J. Virol. Methods 112 (2003) 23-33
14. Huang L.W., Chao S.L., and Lee B.H. Integration of human papillomavirus type-16 and type-18 is a very early event in cervical carcinogenesis. J. Clin. Pathol. 61 (2008) 627-631
15. Hudelist G., Manavi M., Pischinger K.I.D., Watkins-Riedel T., Singer C.F., Kubista E., and Czerwenka K.F. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade. Gynecol. Oncol. 92 (2004) 873-878
16. Kalantari M., Karlsen F., Kristensen G., Holm R., Hagmar B., and Johansson B. Disruption of the E1 and E2 reading frames of HPV 16 in cervical carcinoma is associated with poor prognosis. Int. J. Gynecol. Pathol. 17 (1998) 146-153
17. Klaes R., Woerner S.M., Ridder R., Wentzensen N., Duerst M., Schneider A., Lotz B., Melsheimer P., and von Knebel Doeberitz M. Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res. 59 (1999) 6132-6136
18. Kulmala S.M., Syrjänen S.M., Gyllesten U.B., Shabalova I.P., Petrovichev N., Tosi P., Syrjänen K.J., and Johansson B.C. Early integration of high copy HPV 16 detectable in women with normal and low grade cervical cytology and histology. J. Clin. Pathol. 59 (2006) 513-517
19. Li W., Wang W., Si M., Han L., Gao Q., Luo A., Li Y., Lu Y., Wang S., and Ma D. The physical state of HPV 16 infection and its clinical significance in cancer precursor lesion and cervical carcinoma. J. Cancer Res. Clin. Oncol. (2008) 14
20. Lukaszuk K., Liss J., Wozniak I., Emerich J., and Wójcikowski C. Human papillomavirus type 16 status in cervical carcinoma cell DNA assayed by multiplex PCR. J. Clin. Microbiol. 41 (2003) 608-612
21. Nagao S., Yoshinouchi M., Miyagi Y., Hongo A., Kodama J., Itoh S., and Kudo T. Rapid and sensitive detection of physical status of human papillomavirus type 16 DNA by quantitative real-time PCR. J. Clin. Microbiol. 40 (2002) 863-867
22. Peitsaro P., Johansson B., and Syrjänen S. Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J. Clin. Microbiol. 40 (2002) 886-891
23. Popescu N.C., and Di Paolo J.A. Integration of human papillomavirus 16 DNA and genomic rearrangements in immortalized human keratinocyte lines. Cancer Res. 50 (1990) 1316-1323
24. Smith P.P., Friedman C.L., Bryant E.M., and McDougall J.K. Viral integration and fragile sites in human papillomavirus-immortalized human keratinocyte cell lines. Genes Chromosomes Cancer 5 (1992) 150-157
25. Tonon S.A., Picconi M.A., Bos P.D., Zinovich J.B., Galuppo J., Alonio L.V., and Teyssie A.R. Physical status of the E2 human papillomavirus 16 viral gene in cervical preneoplastic and neoplastic lesions. J. Clin. Virol. 21 (2001) 129-134
26. Zerbini M., Venturoli S., Cricca M., Gallinella G., De Simone P., Costa S., Santini D., and Musiani M. Distribution and viral load of type specific HPVs in different cervical lesions as detected by PCR-ELISA. J. Clin. Pathol. 54 (2001) 377-380
27. zur Hausen H. Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers. Cancer Res. 49 (1989) 4677-4681